Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can acupuncture and Mind-Body therapy help lymphoma survivors reclaim their lives?

NCT ID NCT05982223

Symptom relief Sponsor: Bnai Zion Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 02, 2026 · Last updated Oct 02, 2026

Summary

Lymphoma survivors often face lasting fatigue, pain, and emotional distress after treatment. Researchers at Bnai Zion Medical Center are studying whether integrative medicine, including acupuncture, mind-body therapy, and touch therapy, can improve quality of life and ease symptoms. Ninety adults in remission from lymphoma can choose complementary treatments or join a control group that fills out questionnaires. The study follows participants for two years to track physical, emotional, and social well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
integrative medicine treatments including acupuncture, mind-body therapy, and touch therapy
What this could lead to
If these therapies help, lymphoma survivors could have more options for managing fatigue, pain, and emotional distress after treatment. Integrative care might become a standard part of survivorship programs.
What could go wrong
This is a small study of 90 people at one medical center, and participants choose their own treatments, which can make results hard to interpret. Complementary therapies may not outperform standard supportive care, and any benefits could be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2023

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with a lymphoproliferative disease * Aged 18 years or older * Received chemotherapy, biological treatment or both for treating the lymphoproliferative disease * Defined in remission for less than one year by the haemato-oncologist (maintenance therapy is authorized) * Can respond to questionnaires * Signed informed consent Exclusion Criteria: None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lymphoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lymphoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bnai Zion Medical Center

    RECRUITING

    Haifa, 3339419, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.